Skip to main content

Bipolar Disorders

October 05, 2019
SAN DIEGO—Children with bipolar disorder who were treated with lurasidone had a lower risk of all-cause and psychiatric-related hospitalization than those treated with aripiprazole or olanzapine, according to a retrospective claims database study.
October 04, 2019
SAN DIEGO—Side effects were experienced nearly universally by respondents in an online survey who took oral antipsychotics the previous year for bipolar I disorder, according to results presented at a Psych Congress 2019 poster session.
September 26, 2019
Increased long-term antibody response to cytomegalovirus and decreased long-term antibody response to Toxoplasma gondii were associated with bipolar disorder as well as the subphenotypes of bipolar I.
September 04, 2019
Taking psychiatric medication did not hamper weight loss in people who participated in a structured weight loss program, researchers recently reported online in the journal Obesity. The study compared weight loss outcomes for 17,519 adults enrolled in a lifestyle weight management program at the…
May 28, 2019
Allergan Plc's Vraylar won US regulatory approval to treat depressive episodes of bipolar I disorder, expanding its scope of treatment to a full spectrum of symptoms related to the condition, the company said.
April 18, 2019
A smoking-cessation program tailored to people with schizophrenia and bipolar disorder may help some quit, new findings show.
Back to Top